Adverum Biotechnologies Expands Leadership Team with the Appointment of Peter Soparkar as Chief Legal Officer

MENLO PARK, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of seasoned life sciences executive Peter Soparkar as chief legal officer. Most recently, Mr. Soparkar served as chief legal officer and head of human resources at Counsyl, Inc., prior to the company?s sale to Myriad Genetics and spent 10 years at Jazz Pharmaceuticals, most recently as their vice president and associate general counsel.

Click to view original post